Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Anakinra  Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022 57 5
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Mar/12/2022 17 1
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 41 4
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021 11 2
Lurasidone Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021 2 0
Ascorbic acid Potential treatment - clinical evidence Natural product Other treatment Feb/26/2021 2 0
Resveratrol Potential treatment - pre-clinical evidence Natural product Antiviral Feb/23/2021 2 0
Glucocorticoids Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/06/2021 6 0
Excel (.xslx) CSV (.csv)